Indication
Malignant essential hypertension
Malignant essential hypertension is an acute, life-threatening hypertensive emergency that arises from severe, idiopathic (primary) systemic high blood pressure. Read more about Malignant essential hypertension
3 drugs 3 manufacturers
Drugs that treat it
Common Malignant essential hypertension therapies.
FENOLDOPAM (fenoldopam mesylate)
CORLOPAM (fenoldopam mesylate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMalignant essential hypertension is an acute, life-threatening hypertensive emergency that arises from severe, idiopathic (primary) systemic high blood pressure.
It primarily affects the cardiovascular, renal, ocular, and central nervous systems, frequently presenting in adults with chronic or inadequately controlled underlying hypertension.
Pathophysiologically, it is driven by a breakdown in vascular autoregulation and severe endothelial injury, leading to widespread arteriolar fibrinoid necrosis and microvascular ischemia.
The defining clinical hallmark is extreme arterial blood pressure elevation—commonly exceeding a systolic pressure of 200 mm Hg or diastolic pressure of 120 to 130 mm Hg—accompanied by advanced bilateral retinopathy (flame-shaped hemorrhages, cotton-wool exudates, or papilledema) and rapidly progressive target-organ damage such as acute kidney injury, hypertensive encephalopathy, or heart failure.
- nih.gov
Malignant essential hypertension is an acute, life-threatening hypertensive emergency that arises from severe, idiopathic (primary) systemic high blood pressure It primarily affects the cardiovascular, renal, ocular, and central nervous systems, frequently presenting in adults with chronic or inadequately controlled underlying hypertension The defining clinical hallmark is extreme arterial blood pressure elevation—commonly exceeding a systolic pressure of 200 mm Hg or diastolic pressure of 120 t...
- clevelandclinic.org
Malignant essential hypertension is an acute, life-threatening hypertensive emergency that arises from severe, idiopathic (primary) systemic high blood pressure
- nih.gov
It primarily affects the cardiovascular, renal, ocular, and central nervous systems, frequently presenting in adults with chronic or inadequately controlled underlying hypertension Pathophysiologically, it is driven by a breakdown in vascular autoregulation and severe endothelial injury, leading to widespread arteriolar fibrinoid necrosis and microvascular ischemia The defining clinical hallmark is extreme arterial blood pressure elevation—commonly exceeding a systolic pressure of 200 mm Hg or d...
- nih.gov
Pathophysiologically, it is driven by a breakdown in vascular autoregulation and severe endothelial injury, leading to widespread arteriolar fibrinoid necrosis and microvascular ischemia
- nih.gov
The defining clinical hallmark is extreme arterial blood pressure elevation—commonly exceeding a systolic pressure of 200 mm Hg or diastolic pressure of 120 to 130 mm Hg—accompanied by advanced bilateral retinopathy (flame-shaped hemorrhages, cotton-wool exudates, or papilledema) and rapidly progressive target-organ damage such as acute kidney injury, hypertensive encephalopathy, or heart failure
Personalize your experience
Follow Malignant essential hypertension and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.